The interaction between APE1 and nucleophosmin 1 (NPM1) has been extensively examined in ovarian cancer, as the levels of the two proteins were positively associated with tumor aggressiveness, malignant phenotype, lymph node metastasis, and poor chemosensitivity [114,117]. This evidence concerns the gene NPM1 and ovarian carcinoma.